medRxiv PreprintsInternational20 November 2026
Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Introduction: Postpartum depression (PPD) is a public health problem, affecting approximately 17% of women worldwide. PPD is associated with significant costs to the healthcare system and impairments for the child. Although evidence shows that psychotherapy and pharmacotherapy are effective in reducing PPD symptoms, access to these treatments is limited, especially in low- and middle-income countries where there is a shortage of professionals and unequal distribution of mental health services. In this context, telehealth, smartphone apps, and brief psychotherapies emerge as viable, low-cost, a
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
- Elevated maternal hemoglobin levels during pregnancy are associated with autism spectrum disorder in the offspring: A population-based cohort study20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.